Priority Date: 15.06.12 (US 201261660428P)

DEUTERATED DERIVATIVES OF RUXOLITINIB

  • Application ID: EP13732046
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 2014
Headquarter in Nottingham
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Park Grove IP Ltd is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 185 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2012 - Priority Date (US 201261660428P)
  • 19.12.2013 - Publication A1 (WO2013188783)
  • 22.04.2015 - Publication A1 (EP2861600)